Sign In
Buy ALNY
$216.98
-2.22 (-1.01%)
At Close: Aug 10, 2026
Nisa Investment Advisors LLC Has $5.53 Million Position in Alnylam Pharmaceuticals, Inc. $ALNY
05:54am, Monday, 12'th Jan 2026
Nisa Investment Advisors LLC grew its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 47.2% in the undefined quarter, according to the company in its most recent disclosure with the Securitie
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
05:00pm, Sunday, 11'th Jan 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its new five-year strategy, “Alnylam 2030,” focused on scali
Alnylam Pharmaceuticals, Inc. $ALNY Shares Acquired by Cerity Partners LLC
03:24am, Sunday, 11'th Jan 2026
Cerity Partners LLC boosted its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 171.2% in the third quarter, according to the company in its most recent filing with the SEC. The
Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference
09:15am, Monday, 05'th Jan 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate
Generali Asset Management SPA SGR Has $1.48 Million Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY
06:04am, Monday, 05'th Jan 2026
Generali Asset Management SPA SGR increased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 6,368.0% in the undefined quarter, according to its most recent disclosure with the Securiti
Merit Financial Group LLC Has $1.93 Million Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY
05:16am, Monday, 05'th Jan 2026
Merit Financial Group LLC increased its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 123.9% in the third quarter, according to the company in its most recent filing with the S
Osaic Holdings Inc. Purchases 2,158 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
05:07am, Friday, 02'nd Jan 2026
Osaic Holdings Inc. boosted its position in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 132.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange C
This AI Infrastructure Stock Is 'Most Likely' To Be Added To S&P 500 In Q1 2026 According To Prediction Markets
03:13am, Friday, 02'nd Jan 2026
Vertiv Holdings Co. is expected to be next in line to join the S&P 500 during the first quarter of 2026, according to prediction markets.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of “Moderate Buy” from Brokerages
03:50am, Sunday, 21'st Dec 2025
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY - Get Free Report) have earned an average rating of "Moderate Buy" from the twenty-eight research firms that are covering the company, Marketbeat
This year's biotech laggards primed for 2026 recovery, says Goldman Sachs' Richter
06:25pm, Friday, 19'th Dec 2025
CNBC's “Closing Bell Overtime” team discusses why the biotech recovery may continue into 2026 with Salveen Richter, lead U.S. biotech analyst at Goldman Sachs Research.
Alnylam Pharmaceuticals, Inc. $ALNY Shares Acquired by Assenagon Asset Management S.A.
03:24am, Friday, 19'th Dec 2025
Assenagon Asset Management S.A. increased its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 354.5% during the third quarter, according to its most recent disclosure with the Se
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the planned expansion of its state-of-the-art manufacturing faci
Is Alnylam Entering A Corrective Phase After A Strong Run?
07:04am, Tuesday, 16'th Dec 2025
Alnylam (NASDAQ: ALNY) has corrected by roughly 13% over the past couple of weeks. To understand why this pullback is unfolding now, it is important to examine the stock's structure through the lens o
Nasdaq-100 Shake-Up: These 6 Stocks Are In, 6 Are Out — And It Could Trigger Big Moves
06:01am, Monday, 15'th Dec 2025
The Nasdaq-100 Index has announced its annual reconstitution, with six new companies being added and six being removed, effective December 22, 2025.
Alnylam Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027
07:00am, Thursday, 11'th Dec 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (“Alnylam”) (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has entered into separate, privately neg
